India to United States: Hydroxychloroquine Export Trade Route
India has recorded 264 verified shipments of Hydroxychloroquine exported to United States, representing a combined trade value of $122.3M USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $463.3K USD. The leading Indian exporter is ZYDUS LIFESCIENCES LIMITED, which accounts for 91% of total export value with 200 shipments worth $110.8M USD. On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer in United States with $112.0M USD in purchases. The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD — together control 97% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to United States Hydroxychloroquine corridor is one of India's established pharmaceutical export routes, with 264 shipments documented worth a combined $122.3M USD. The route is dominated by ZYDUS LIFESCIENCES LIMITED, which alone accounts for roughly 91% of all export value, reflecting the consolidated nature of India's hydroxychloroquine manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $463.3K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 84% of all shipments, consistent with hydroxychloroquine's non-urgent bulk-order profile.
Shipment activity peaks during April–June, with an average transit time of 34 days port-to-port. The route has recorded an annual growth rate of 21.6%, placing it at rank #18 among India's top hydroxychloroquine export destinations globally.
On the import side, key buyers of Indian hydroxychloroquine in United States include EVERSANA LIFE SCIENCE SERVICES, NORTHSTAR DISTRIBUTION CENTER 8912, NA and 16 others. EVERSANA LIFE SCIENCE SERVICES is the single largest importer with 188 shipments valued at $112.0M USD.
Route Characteristics
- Average transit34 days
- Peak seasonQ2
- Primary modeSea freight
- Top portMUNDRA SEA
Market Position
- Global rank#18
- Annual growth+21.6%
- Demand growth+20.2%
- Regulatory ease88/100
Top 10 Indian Hydroxychloroquine Exporters to United States
Showing top 10 of 10 Indian suppliers exporting Hydroxychloroquine to United States, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | ZYDUS LIFESCIENCES LIMITED Avg $553.9K per shipment | 200 | $110.8M | 90.6% |
| 2 | CADILA HEALTHCARE LIMITED Avg $196.3K per shipment | 30 | $5.9M | 4.8% |
| 3 | CADILA HEALTHCARE LTD Avg $234.6K per shipment | 9 | $2.1M | 1.7% |
| 4 | IPCA LABORATORIES LIMITED Avg $215.9K per shipment | 6 | $1.3M | 1.1% |
| 5 | INTAS PHARMACEUTICALS LIMITED Avg $92.3K per shipment | 8 | $738.2K | 0.6% |
| 6 | LAURUS LABS LTD Avg $284.0K per shipment | 2 | $568.0K | 0.5% |
| 7 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED Avg $271.9K per shipment | 2 | $543.8K | 0.4% |
| 8 | AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED Avg $193.7K per shipment | 2 | $387.5K | 0.3% |
| 9 | ARHANT SALES CORPORATION Avg $280 per shipment | 2 | $560 | 0.0% |
| 10 | ESR ENTERPRISES Avg $90 per shipment | 3 | $270 | 0.0% |
This table shows the top 10 of 10 Indian companies exporting hydroxychloroquine to United States, ranked by total trade value. The listed exporters are: ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD, IPCA LABORATORIES LIMITED, INTAS PHARMACEUTICALS LIMITED, LAURUS LABS LTD, AMNEAL PHARMACEUTICALS PRIVATE LIMITED, AMNEAL PHARMACEUTICALS COMPANY (I) PRIVATE LIMITED, ARHANT SALES CORPORATION, ESR ENTERPRISES. ZYDUS LIFESCIENCES LIMITED is the dominant supplier with 200 shipments worth $110.8M USD, giving it a 91% market share. The top 3 suppliers together account for 97% of the total trade value on this route.
Top 10 Hydroxychloroquine Importers in United States
Showing top 10 of 19 known buyers in United States receiving Hydroxychloroquine shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian hydroxychloroquine in United States include EVERSANA LIFE SCIENCE SERVICES, NORTHSTAR DISTRIBUTION CENTER 8912, NA, PRIORITY HEALTHCARE DISTRIBUTION DB, EVERSANA LIFE SCIENCE SERVICES,, among 19 total buyers. The largest importer is EVERSANA LIFE SCIENCE SERVICES, accounting for $112.0M USD across 188 shipments — representing 92% of all hydroxychloroquine imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | EVERSANA LIFE SCIENCE SERVICES | 188 | $112.0M | 91.6% |
| 2 | NORTHSTAR DISTRIBUTION CENTER 8912 | 33 | $4.4M | 3.6% |
| 3 | NA | 6 | $1.3M | 1.1% |
| 4 | PRIORITY HEALTHCARE DISTRIBUTION DB | 7 | $814.6K | 0.7% |
| 5 | EVERSANA LIFE SCIENCE SERVICES, | 3 | $638.2K | 0.5% |
| 6 | Amneal EU Limited | 2 | $543.8K | 0.4% |
| 7 | PRIORITY HEALTHCARE DISTRIBUTION | 3 | $520.6K | 0.4% |
| 8 | XXNEAXXEU XXMITXX | 2 | $387.5K | 0.3% |
| 9 | EVERSANA LIFE SCIENCES SERVICES,LLC | 4 | $369.3K | 0.3% |
| 10 | EVERSANA LIFE SCIENCES SERVICES LLC | 4 | $368.9K | 0.3% |
Showing top 10 of 19 Hydroxychloroquine importers in United States on this route.
Top 10 Hydroxychloroquine Formulations Imported by United States
Showing top 10 of 103 product formulations shipped on the India to United States Hydroxychloroquine route, ranked by trade value
United States imports a wide range of hydroxychloroquine formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — PHARMA : HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG (HYDROXYCHLOROQUINE SULFATE USP 200MG) - 6180 PAC X 1X500 TABS — accounts for $82.9M USD across 1 shipments. There are 103 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | PHARMA : HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG (HYDROXYCHLOROQUINE SULFATE USP 200MG) - 6180 PAC X 1X500 TABS | 1 | $82.9M | 67.8% |
| 2 | HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG | 25 | $5.0M | 4.1% |
| 3 | PHARMA : HYDROXYCHLOROQUINE SULFATE TABL | 12 | $2.8M | 2.3% |
| 4 | HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MGTBS | 9 | $1.4M | 1.1% |
| 5 | PHARMACEUTICAL MEDICINE FOR HUMAN USE -HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG 1 X 100T | 10 | $1.3M | 1.0% |
| 6 | HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG (OTHER DETAILS AS PER INV & P.LIST) | 11 | $1.2M | 0.9% |
| 7 | PHARMACEUTICAL MEDICINE FOR HUMAN USE- HYDROXYCHLOROQUINE SULFATE TABLETS USP 200 MG - 1 X 500 | 5 | $1.1M | 0.9% |
| 8 | HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG 1X100T | 3 | $923.1K | 0.8% |
| 9 | HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG DIST. NDC - 68382-096-05 MFG. NDC -65841-633-05 (AS PER INVOICE. & P.LIST) | 4 | $737.7K | 0.6% |
| 10 | HYDROXYCHLOROQUINE SULFATE TABLETS USP 200MG [1X100 PER PACK] | 4 | $664.7K | 0.5% |
Showing top 10 of 103 Hydroxychloroquine formulations imported by United States on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 84%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
MUNDRA SEA handles the highest volume with 130 shipments. Transit time averages 34 days by sea.
Market Dynamics
India's hydroxychloroquine exports to United States are driven primarily by a handful of large-scale manufacturers. ZYDUS LIFESCIENCES LIMITED with 200 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in United States benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD — together account for 97% of total trade value on this route. The average shipment value of $463.3K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.
Beyond the primary product category, shipments on this route include closely related formulations such as hydroxychloroquine sulfate tablets usp 200mg and pharma : hydroxychloroquine sulfate tabl, suggesting that buyers in United States tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, EVERSANA LIFE SCIENCE SERVICES is the largest importer with 188 shipments worth $112.0M USD — representing 92% of all hydroxychloroquine imports from India on this route. A total of 19 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $122.3M
- Avg. Shipment
- $463.3K
- Suppliers
- 10
- Buyers
- 19
- Transit (Sea)
- ~34 days
- Annual Growth
- +21.6%
Related Analysis
Reverse Direction
United States → India — Hydroxychloroquine (Import)Other Hydroxychloroquine Routes
Unlock the Full India to United States Hydroxychloroquine Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 264 shipments on this route.
Frequently Asked Questions — India to United States Hydroxychloroquine Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Hydroxychloroquine to United States?
The leading Indian exporters of Hydroxychloroquine to United States are ZYDUS LIFESCIENCES LIMITED, CADILA HEALTHCARE LIMITED, CADILA HEALTHCARE LTD. ZYDUS LIFESCIENCES LIMITED holds the largest market share at approximately 91% of total trade value on this route.
Q What is the total value of Hydroxychloroquine exports from India to United States?
India exports Hydroxychloroquine to United States worth approximately $122.3M USD across 264 recorded shipments. The average value per shipment is $463.3K USD.
Q Which ports does India use to ship Hydroxychloroquine to United States?
The most active port of origin is MUNDRA SEA with 130 shipments. Indian exporters primarily use sea freight for this route, with 84% of shipments going by sea and 29% by air.
Q How long does shipping take from India to United States for Hydroxychloroquine?
The average transit time for Hydroxychloroquine shipments from India to United States is approximately 34 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during April–June.
Q Is the India to United States Hydroxychloroquine trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 21.6% with demand growth tracking at 20.2%. The route is ranked #18 among India's top Hydroxychloroquine export destinations globally.
Q How many suppliers are active on the India to United States Hydroxychloroquine route?
There are currently 10 active Indian suppliers exporting Hydroxychloroquine to United States. The market is moderately concentrated with ZYDUS LIFESCIENCES LIMITED accounting for 91% of total shipment value.
Q Who are the main importers of Hydroxychloroquine from India in United States?
The leading importers of Indian Hydroxychloroquine in United States include EVERSANA LIFE SCIENCE SERVICES, NORTHSTAR DISTRIBUTION CENTER 8912, NA, PRIORITY HEALTHCARE DISTRIBUTION DB, EVERSANA LIFE SCIENCE SERVICES,. EVERSANA LIFE SCIENCE SERVICES is the largest buyer with 188 shipments worth $112.0M USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to United States export trade corridor identified from Indian Customs (DGFT) records for Hydroxychloroquine.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 19 importers in United States matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 264 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
264 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists